Lower dose blood thinners for heart pump patients
Treatments studied
Part of Brain & nervous system, Digestive system, Heart & circulation clinical trials.
This study tests whether a lower dose of blood thinners can reduce bleeding problems while still preventing blood clots in people who have a HeartMate 3 heart pump. If you are stable on your current blood thinner, this trial might help you avoid serious bleeding complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have a HeartMate 3 heart pump that has been in place for at least 30 days.
- Your blood thinner levels have been stable (INR between 2.0 and 3.0) for at least 30 days.
- You have not had a stroke or mini-stroke in the past 6 months.
- You have not had major bleeding (like stomach or brain bleeding) in the past 6 months.
- You do not have severe kidney or liver disease, active infection, or other major health problems that would make this trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.
This study compares two blood thinners for people who have a HeartMate 3 left ventricular assist device (LVAD). The goal is to see if the newer medicine, apixaban, works better or has fewer side effects than the standard medicine, warfarin.
This Phase 3 study tests whether aiming for a lower blood-thinning test result (INR) can reduce bleeding risk in people with a specific type of mechanical heart valve. The trial checks if this lower INR goal is safer while still protecting against dangerous clots.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This study compares different ways of using blood thinners during procedures to fix a leaky mitral valve or close the left atrial appendage. The goal is to find the safest approach to prevent strokes and bleeding.
Hear when a new Advanced Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.